Principal Investigator
Raphael Yechieli
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230815
Clinical Trial Summary
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or without SBRT for PD-L1-Negative, Advanced Non-small Cell Lung Cancer
Phase
Phase II/III
Funding Agency/Sponsor
National Cooperative Group
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647